Insulin-like growth factor 1 (IGF1) dramatically increased DNMT1 expression in hepatocellular carcinomas (HCCs) via Akt/GSK-3β signaling pathway activation [36]. The gene discussed is IGF1; the disease is hepatocellular carcinoma.